User: Guest  Login
Title:

Tirapazamine plus cisplatin and irradiation in a mouse model: improved tumor control at the cost of increased toxicity.

Document type:
Journal Article; Article
Author(s):
Adam, M; Bayer, C; Henke, J; Grosu, A; Molls, M; Nieder, C
Abstract:
PURPOSE: Tirapazamine (TPZ) reportedly enhances the tumor cell killing effect of cisplatin up to fivefold and it is an attractive drug for combination with radiotherapy. We evaluated the toxicity of a fractionated combined treatment. METHODS: Murine RIF-1 fibrosarcomas growing on the right hind foot of C3-H mice were used. Within 2 weeks, animals were treated with six i.p. injections of TPZ (43.2-172.8 mg/kg total), and/or cisplatin (24 mg/kg total) and ten fractions of 2 Gy to the tumor. All tr...     »
Journal title abbreviation:
J Cancer Res Clin Oncol
Year:
2008
Journal volume:
134
Journal issue:
2
Pages contribution:
137-46
Language:
eng
Fulltext / DOI:
doi:10.1007/s00432-007-0260-7
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/17622558
Print-ISSN:
0171-5216
TUM Institution:
Klinik und Poliklinik für RadioOnkologie und Strahlentherapie
 BibTeX